ni2o, Inc. products

Countering Communicable Diseases with our Five-Minute Test. Worldwide Testing Challenges: COVID-19 has opened our eyes to the many communities who don’t have adequate disease detection technology. Ni2o’s RapidTest instrument will allow for a variety of diseases to be detected from samples collected via a non-invasive method, removing the need for specialized testing equipment and personnel. While we hope to not endure something as devastating as COVID-19 in the near future, another pandemic may be inevitable. A lag in testing can overwhelm labs and hospitals, allowing a contagious disease to spread almost undetected.

Our Kinetic Intelligent Wireless Implant (KIWI) is a small, self-contained, wirelessly connected, wirelessly charged, AI-driven replacement for current deep brain stimulation (DBS) solutions. KIWI will record brain activity and deliver electrical and optical signals to target areas, with algorithms that will determine the therapeutic response and be continually improved by machine learning. It is implanted using an internally-developed, minimally-invasive surgical procedure. A cloud-based software platform will then securely collect and interpret information in real-time.